跳至主要内容
临床试验/NCT00573456
NCT00573456Unknown1 期

Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Diabetes

GAAD Medical Research Institute Inc.2 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2006年5月1日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
2
试验地点
2
主要终点
The primary end point is to determine the therapeutic effects of far infrared radiation on all types of diabetes.

研究概览

简要总结

A study to determine the use of far infrared (FIR) radiation for treatment of diabetes.

详细描述

Diabetes mellitus is a disease in which glucose is not sufficiently metabolized. This results in high glucose levels in blood and glucose in the urine. Cells can starve because glucose is not being metabolized.

Both types of diabetes can cause dangerous complications, including blindness, heart and blood vessel disease, and kidney failure. A decrease in circulation may eventually require the amputation of limbs.

We are postulating that energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to enhance the immune system; thereby improving the health of the patients.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Persons with type 1 or type 2 diabetes

排除标准

  • 未提供

结局指标

主要结局

The primary end point is to determine the therapeutic effects of far infrared radiation on all types of diabetes.

时间窗: 2 years

次要结局

  • The secondary end point of the study is to evaluate the therapeutic effects of far infrared radiation on other types of diabetes complications including blindness, heart and blood vessel disease and kidney failure.(2 years)

研究者

发起方
GAAD Medical Research Institute Inc.
申办方类型
Other

研究点 (2)

Loading locations...

相似试验